Oxidative stress in non-small cell lung cancer patients after chemotherapy: Association with treatment response

Respirology

Volumn 15, Issue 2, 2010, Pages 349-356

  Gupta, Abhilasha ^a   Srivastava, Shruti ^a   Prasad, Rajendra ^b   Natu, Shanker M ^a   Mittal, Balraj ^c   Negi, Mahendra P S ^d   Srivastava, Anand N ^a  

^a Era's Lucknow Medical College and Hospital   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^d CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Chemotherapy; Non responder; Oxidative stress; Responder; Survival

Indexed keywords

CISPLATIN; ETOPOSIDE; GLUTATHIONE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID PEROXIDATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; OXIDATIVE STRESS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CISPLATIN; ETOPOSIDE; FEMALE; GLUTATHIONE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIPID PEROXIDATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 76249105613     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01703.x     Document Type: Article

References (52)

1. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997 111: 1718 1723.
2. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2007. CA Cancer J. Clin. 2007 57: 43 66.
3. Alberts WM. Follow up and surveillance of the patient with lung cancer: what do you do after surgery? Respirology 2007 12: 16 21.
4. Bunn PA Jr., Kelly K. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions. Clin. Cancer Res. 1998 4: 1087 1100.
5. Brahmer JR, Ettinger DS. Non-small cell lung cancer: adjuvant and neo-adjuvant chemotherapy. Respirology 2007 12: 320 325.
6. Mantovani G, Maccio A, Madeddu C et al. Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status. Int. J. Cancer 2002 98: 84 91.
7. Mantovani G, Maccio A, Lai P et al. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Semin. Oncol. 1998 25: 45 52.
8. Bakan N, Taysi S, Yilmaz O et al. Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia. Clin. Chim. Acta 2003 338: 143 149.
9. Halliwell B. The chemistry of free radicals. Toxicol. Ind. Health 1993 9: 1 21.
10. Look MP, Musch E. Lipid peroxides in the polychemotherapy of cancer patients. Chemotherapy 1994 40: 8 15.
11. Sugihara K, Nakano S, Gemba M. Effect of cisplatin on in vitro production of lipid peroxides in rat kidney cortex. Jpn. J. Pharmacol. 1987 44: 71 6.
12. Sangeetha P, Das UN, Koratkar R et al. Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic. Biol. Med. 1990 8: 15 19.
13. Takahashi K, Takita T, Umezawa H. [Generation of superoxide anion by the reaction of bleomycin-Cu (II) with cysteine]. Jpn. J. Antibiot. 1987 40: 735 738.
14. Wink DA, Cook JA, Kim SY et al. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J. Biol. Chem. 1997 272: 11147 11151.
15. Sayed-Ahmed MM, Mansour HH, Gharib OA et al. L-carnitine modulates bleomycin-induced oxidative stress and energy depletion in lung tissues. J. Egypt Natl. Cancer Inst. 2004 16: 237 243.
16. Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 1994 305: 253 264.
17. Weijl NI, Cleton FJ, Osanto S. Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat. Rev. 1997 23: 209 240.
18. Nowak D, Janczak M. Effect of chemotherapy on serum end-products of lipid peroxidation in patients with small cell lung cancer: association with treatment results. Respir. Med. 2006 100: 157 166.
19. Patterson RA, Leake DS. Human serum, cysteine and histidine inhibit the oxidation of low density lipoprotein less at acidic pH. FEBS Lett. 1998 434: 317 321.
20. Stahl W, Junghans A, de Boer B et al. Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. FEBS Lett. 1998 427: 305 308.
21. Kaynar H, Meral M, Turhan H et al. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Cancer Lett. 2005 227: 133 139.
22. Meister A. New aspects of glutathione biochemistry and transport: selective alteration of glutathione metabolism. Fed. Proc. 1984 43: 3031 3042.
23. Heymann AD. Semilateral decubitus breast examination. JAMA 1980 243: 1713 1714.
24. Hirose K, Longo DL, Oppenheim JJ et al. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J. 1993 7: 361 368.
25. Kuninaka S, Ichinose Y, Koja K et al. Suppression of manganese superoxide dismutase augments sensitivity to radiation, hyperthermia and doxorubicin in colon cancer cell lines by inducing apoptosis. Br. J. Cancer 2000 83: 928 934.
26. Torun M, Yardim S, Gonenc A et al. Serum beta-carotene, vitamin E, vitamin C and malondialdehyde levels in several types of cancer. J. Clin. Pharm. Ther. 1995 20: 259 263.
27. Weijl NI, Hopman GD, Wipkink-Bakker A et al. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann. Oncol. 1998 9: 1331 1337.
28. Beutler E, West C, Blume KG. The removal of leukocytes and platelets from whole blood. J. Lab. Clin. Med. 1976 88: 328 333.
29. Lowry OH, Rosebrough NJ, Farr AL et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951 193: 265 275.
30. Sanocka D, Miesel R, Jedrzejczak P et al. Oxidative stress and male infertility. J. Androl. 1996 17: 449 454.
31. McCord JM, Fridovich I. The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J. Biol. Chem. 1969 244: 6056 6063.
32. Evans JC, Ellman GL. The ionization of cysteine. Biochim. Biophys. Acta 1959 33: 574 576.
33. Green LC, Wagner DA, Glogowski J et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 1982 126: 131 138.
34. Mantovani G, Madeddu C, Gramignano G et al. An innovative treatment approach for cancer-related anorexia/cachexia and oxidative stress: background and design of an ongoing, phase III, randomized clinical trial. Support Cancer Ther. 2007 4: 163 167.
35. Esme H, Cemek M, Sezer M et al. High levels of oxidative stress in patients with advanced lung cancer. Respirology 2008 13: 112 116.
36. Ladner C, Ehninger G, Gey KF et al. Effect of etoposide (VP16-213) on lipid peroxidation and antioxidant status in a high-dose radiochemotherapy regimen. Cancer Chemother. Pharmacol. 1989 25: 210 212.
37. Seven A, Civelek S, Inci E et al. Evaluation of oxidative stress parameters in blood of patients with laryngeal carcinoma. Clin. Biochem. 1999 32: 369 373.
38. Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mutat. Res. 1999 424: 83 95.
39. Gonenc A, Ozkan Y, Torun M et al. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J. Clin. Pharm. Ther. 2001 26: 141 144.
40. Huang YL, Sheu JY, Lin TH. Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin. Biochem. 1999 32: 131 136.
41. Bakan E, Taysi S, Polat MF et al. Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn. J. Clin. Oncol. 2002 32: 162 166.
42. Seven A, Erbil Y, Seven R et al. Breast cancer and benign breast disease patients evaluated in relation to oxidative stress. Cancer Biochem. Biophys. 1998 16: 333 345.
43. Gerber M, Astre C, Segala C et al. Oxidant-antioxidant status alterations in cancer patients: relationship to tumor progression. J. Nutr. 1996 126: 1201S 7S.
44. Taysi S, Koc M, Buyukokuroglu ME et al. Melatonin reduces lipid peroxidation and nitric oxide during irradiation-induced oxidative injury in the rat liver. J. Pineal Res. 2003 34: 173 177.
45. Koh E, Noh SH, Lee YD et al. Differential expression of nitric oxide synthase in human stomach cancer. Cancer Lett. 1999 146: 173 180.
46. Husain K, Whitworth C, Somani SM et al. Carboplatin-induced oxidative stress in rat cochlea. Hear. Res. 2001 159: 14 22.
47. Hannemann J, Duwe J, Baumann K. Iron-and ascorbic acid-induced lipid peroxidation in renal microsomes isolated from rats treated with platinum compounds. Cancer Chemother. Pharmacol. 1991 28: 427 433.
48. Guner G, Islekel H, Oto O et al. Evaluation of some antioxidant enzymes in lung carcinoma tissue. Cancer Lett. 1996 103: 233 239.
49. Mancini M, Sedghinasab M, Knowlton K et al. Flow cytometric measurement of mitochondrial mass and function: a novel method for assessing chemoresistance. Ann. Surg. Oncol. 1998 5: 287 295.
50. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000 21: 485 495.
51. Schmitt CA, Lowe SW. Apoptosis and therapy. J. Pathol. 1999 187: 127 137.
52. Shacter E, Williams JA, Hinson RM et al. Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis. Blood 2000 96: 307 313.